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A Linacre Institute Paper 
Rape Protocol 
by 
Eugene F. Diamond, M.D. 
The occurrence of forcible rape is an event which appropriately calls forth an 
intense emotional climate of condemnation for the perpetrator and sympathy for 
the victim.) There has been a salutary change in the attitudes of society toward 
this crime of violence, including well-organized measures to improve the 
aftercare of the rape victim. Most states have statutes which require hospitals to 
establish written protocols for the care of rape victims particularly in emergency 
room settings. This has created conflicts for Catholic institutions with regard to 
the recommendation for the use of so-called "morning-after" pill in rape 
protocols.2 The conflict relates to the action of hormones (large doses of estrogen 
or estrogen-progestogen combinations) given during the post-rape period and the 
intentionality of the health care provider in dispensing the hormones or referring 
to agencies which will provide them. The crux of the matter is whether the 
"morning-after" pill is an abortifacient through its effect in preventing 
implantation or whether it can be a contraceptive through an effect of preventing 
ovulation when given early in the cycle. 
Contraception FoUowing Rape 
The essentially immoral character of contraception is its "failure to preserve 
the full sense of mutual self-giving and human procreation" (Gaudium et. spes 
51). The wrongfulness of contraception has to do with a decision to bring oneself 
into sexual union with another person and another decision positively to preclude 
the transmission of new life (Familiaris Consortrio 32). The woman who has 
been raped has not made the free choice of sexual union, and she is, therefore, free 
to attempt to neutralize the effects of the assault which violated her bodily 
integrity. In a practical sense, this might involve attempts to prevent sperm 
transport or sperm capacitation or to suppress ovulation. 
Abortifacient Effects 
"Morning-after" pills given to a woman who has already conceived as a result 
of forcible rape will alter the tubal transport of the zygote and will interfere with 
the implantation of the blastocyst.3 The prevention of implantation is an 
abortifacient effect, and abortion is no less immoral and repugnant when it occurs 
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in the earliest stages of intrauterine development. There have been attempts to 
redefine "contraception" to include the prevention of implantation by declaring 
the stages between fertilization and implantation to be "pre-embryonic". The 
American College of Obstetrics and Gynecology defines pregnancy as beginning 
with implantation, but this manipulation of language is not related to modem 
scientific understanding so much as the need to fulfill a political agenda. 
During the period between fertilization and implantation, the embryo 
independently controls a sequence of events which are critical to its survival. The 
single-cell zygote divides and differentiates into a cluster of cells. The outer layer 
of cells secretes chorionic gonadotropin and develops the capacity to adhere and 
invade the endometrial lining. Drugs which interfere with these stages of human 
development are abortifacients, not contraceptives. 
Postcoital Contraception 
A statement approved by the British Bishops4 attempts to refine the issue by 
distinguishing the effects of estrogen or estrogen-progestogen combinations 
depending on the stage in the menstrual cycle at which they are administered. 
The statement distinguishes three stages: 
1) If administered prior to ovulation, the effect would be to prevent ovulation 
and thereby fertilization by producing an anovulatory cycle. 
2) If administered just before ovulation, high doses of hormone may prevent 
conception by a) immobilizing sperm in the genital tract, b) by preventing 
capacitation ofthe sperm, or c) affecting the cells surrounding the ovum 
during the ovum's own preparation. 
3) If administered after ovulation, the effect, if any, will be abortifacient 
through a) alteration in the environment of the fallopian tube, b) inhibition 
of implantation by the creation of a hostile environment in the 
endometrium and, c) hormonal effects producing shedding of the 
endometrium and loss of the implanting embryo. 
The statement proposes that hormonal postcoital treatment be approved after 
insemination by sexual assault provided· 1) There are no grounds for jUdging that 
ovulation preceded or will coincide with the administration of hormones and 2) 
The postcoital hormone is administered during the first 24-hours after rape. 
The statement must be critically examined from two standpoints: 1) whether 
or not the effects of hormones are truly as stated during the three stages of the 
menstrual cycle and 2) whether or not the possibility of ovulation can be excluded 
by history given the real-life circumstances of the aftercare of the rape victim . 
. ~ Suppression of Ovulation Early in the Cycle 
~ The usual measure employed for postcoital contraception is 100 mcg. of 
Ovral (an estrogen-progestogen combination) followed 12 hours later by a 
second 100 mcg. dose of Ovral. Since Ovral is manufactured by Wyeth-Ayerst 
~ Pharmaceuticals, an inquiry was submitted to the company regarding evidence 
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that Ovral does, in fact, act as an anti-ovulant in the aforementioned dosage 
schedule. The company provided referencess,6,7,8,9 regarding the use of d 1-
norgestrel and ethinyl estradiol (the hormonal components of Ovral) as a 
postcoital contraceptive. 
From the experimental data provided by the manufacturer, it can be inferred 
that the scientific evidence to support the suppression of ovulation by two 100 
mcg. doses of Ovral twelve hours apart is meager and inconclusive. The company 
does not, in fact, claim such an effect. One recent publication 10 suggests that 
RU-486 may disrupt follicular maturation, but it is unlikely that the rape protocol 
of a Catholic hospital would want to recommend this French abortion pill. 
1. Effects on Sperm - Progestogen changes the quality of the cervical 
mucus to make penetration by spermatozoa more difficult. According to 
experimental evidence observed by Klaus,11 however, sperm traverse the cervical 
mucus at peak phase (time of ovulation) in a period of 90 seconds. Altering the 
cervical mucus by Ovral given hours ,after the assault would not preclude free 
access by sperm to the uterus. 
2. Spenn Transport - Sperm transport time from the cervical os to the 
oviduct has been variously estimated. 12, 13, 14 The best evidence is that this occurs in 
minutes, possibly as soon as five minutes after intercourse. IS It is highly unlikely 
that postcoital hormone therapy could cause immobilization of all or most of the 
sperm in time to prevent their access to the tube and thereby fertilization. 
3. Spenn Capacitation - Sperm Capacitation is the process by which the 
sperm acquires the capability to cleave to and penetrate the ovum. Although this 
usually occurs after a period of time in the female genital tract, it is also acquired 
in the human outside the body such as in in-vitro fertilization. Ovral, which 
contains progestogen can theoretically interfere with capacitation by impeding 
the release of progesterone which is important in capacitation. Large doses of 
Ovral could reduce sperm capacitation, but it is unlikely that it could prevent all 
sperm capacitation prior to their migration and cleavage to the ovum. The 
numbers of capacitated sperm reaching the ovum would be reduced to the extent 
determined by the timing of hormone administration. 
4. Tubal Motility - Large doses of estrogen reduce motility and ciliary 
action in the oviduct. The timing of this effect in a post-rape situation indicates 
that it would not interfere with sperm reaching the ovum so much as preventing 
fertilized ova from moving back down the tube in proper phase for implantation. 
The two most frequently quoted studies regarding the mechanisms of action of 
"morning-after" pills are those of Blye16 and Kuchera.17 These authors stress the 
following effects of postcoital agents: 
a. Prevention of tubal transport of the zygote 
b. Prevention of embryonic viability 
c. Prevention of sperm transport 
d. Loss of sperm viablity 
e. Luteolysis 
f. Prevention of implantation 
As Blye states in his article, "it is somewhat rhetorical to include the effects on 
male gametes here inasmuch as postcoital contraceptive therapy is contemplated 
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long after spermatozoa have reached the site of fertilization in the female 
reproductive tract." In summary, then, the logistics of the real life situation of the 
aftercare of a rape victim are such that the only relevant effect of postcoital 
hormonal agents is their ability to prevent implantation. 
Menstrual History 
A key factor in evaluating the use of "morning-after" pills under the guidelines 
of the British Bishops' report is the woman's ability to provide reliable historical 
evidence as to how an act of intercourse has been timed in her menstrual cycle. In 
order to know whether it is licit to use Ovral, the attending physician should be 
aware of whether the woman is pre-ovulatory, ovulating, or post-ovulatory. How 
reliable is such historical evidence? A recent study published in the New England 
Journal of Medicine1s is of interest since all women in the study had laboratory 
surveillance by way of plasma progesterone and urine pregnanediol levels. This 
allowed objective laboratory confirmation of the women's subjective statements 
about their cycles. Fifty-one percent of women who were believed to be in the 
luteal phase by history had not ovulated. Twenty-one percent of women thought 
to be pre-ovulatory, by their statements had, in fact, ovulated. The conclusion of 
this objective hormone assay-controlled study was "most women do not keep 
records of their menstrual periods and it is well-rocognized that estimated dates 
are likely to be inaccurate': Given the uncertainty of information available at the 
time of treatment, it is unlikely that the standard required by the British Bishops' 
statement (i.e., "There are no grounds for judging that ovulation preceded or will 
coincide with the administration of hormones") is achievable with any 
acceptable degree of certitude. 
Risk of Pregnancy After a Single Act of Forcible Rape 
Support for the use of postcoital agents is developed from studies done on 
populations other than rape victims such as women on college campuses who 
approach student health centers after an episode of "unprotected intercourse". 
These studies compare the number of pregnancies following postcoital hormone 
administration with the number expected following a single act of random 
unprotected intercourse in any menstrual cycle. It has been noted19 that many of 
these studies have a methodological error, i.e., using the total number of women 
in the study as the denominator rather than the number of women actually 
potentially pregnant. Also using the Tietze20 estimate of the expected incidence of 
pregnancy following a single act of random unprotected intercourse as 3% may 
be unrealistically high as compared with that of Pearl (0.3%). However accurate 
these studies are, however, there is question as to whether the statistics truly apply 
to the situation of a single act of forcible rape. 
In a prospective study of 4,000 rapes in Minnesota, no pregnancies were 
reported.22 In a retrospective study, the States Attorney of Cook County, Illinois, 
including Chicago, reported no pregnancies during a nine-year period of 
prosecutions for rape. Similar retrospective studies done by law enforcement 
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agencies in Erie County, New York, and Cuyahoga County, Ohio, reported not a 
single pregnancy following rape in prosecutions covering thirty years in New 
York and ten years in Ohio.23 In a prospective study of 117 rapes, there were no 
pregnancies among the 100 women who received no post-rape hormones.24 
While not all rapes are reported, there is no reason to think that pregnancy is 
more common after unreported rape than it is after reported rape. Some recent 
studies have helped to shed light on this lower-than-expected incidence of 
pregnancy following forcible rape. 
1. There is a high rate of sexual dysfunction related to sexual assault. Groth 
and Burgess reported2S that 57% of 10 1 rapists had erective or ejaculatory 
dysfunction. 
2. Rape is defined legally as penetration with or without ejaculation. A series 
of studies26 have reported the recovery of spermatozoa from only about half 
of rape victims including even victims of gang rape. 
3. About 70% of rape victims will be at reduced risk because they are on 
contraceptives, are pregnant, post-menopausal, pre-menarchal or were 
surgically steri1ized.27 . 
Legal Issues 
In the case of Brown/eld vs. Daniel Freemand Marina Hospital [256 Cal. Rptr. 
240 (cr. app. second distribution 1989)] a rape victim sued for declaratory and 
injunctive relief because of the failure of a Catholic hospital where she was 
treated to provide rape victims with information about and access to estrogen 
pregnancy prophylaxis in the emergency room. The case was dismissed in the 
trial court and the decision was upheld on appeal because the plaintiff had 
claimed no damages as a result of the failure to provide information or access. 
In dicta accompanying the decision, the court suggests that Catholic hospitals 
might have a responsibility to "instruct the patient concerning options for 
pregnancy prevention" or "to transfer the patient to another facility." No 
hospital, obviously, is required to cooperate in abortion or to refer for abortion 
given the protection of State and Federal conscience clauses.28 Catholic hospitals 
can provide comprehensive services for rape victims through cooperation with 
Catholic Social Services and consultants from the Catholic Physicians Guilds. 
The evidence that "morning-after" pills are, in fact, abortifacient is 
overwhelming and irrefutable.29,30,31,32 The use of postcoital hormonal agents is 
not standard therapy after rape.33,34 There is no litigated case in which denial of 
"morning-after" pills following rape has resulted in a greater risk of pregnancy. 
Ethical Issues 
It has been suggested by the British Bishops repoct4 that "morning after" pills . 
may be given if there is a doubt as to whether ovulation has occurred. Us~g the . 
principle of double effect, the "intention" of the person recommending the drug is 
to prevent ovulation and not to prevent implantation. There are two problems 
with this rationale. 1) There is formidable evidence that postcoital estrogens do 
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not prevent ovulation3S and 2) aside from the 10% of Catholics and the 5% of the 
general population using reliable methods of Natural Family Planning, there 
would always be an irreconcilable doubt as to whether ovulation has occurred.2 
The choice then would seem to be between a medication which is either 
ineffective or contraindicated. As the British Bishops state in their reply to 
criticisms of their original statement "the upright and informed conscience will 
not be willing to accept any substantial risk of killing the embryo."36 
Other ethical issues have been summarized by Rohlfs37 as follows: 
"Some will also defend the use of Ovral by the Principle of Double Effect. The 
Principle of Double Effect cannot be used in the case of Ovral for several reasons. 
First, it does not have two effects in a particular instance, but only one or the other 
of two possible effects. As we have stated earlier, most of the time in a post-rape 
situation Ovral will do nothing successful as either contraceptive or abortifacient. 
But, if Ovral does anything successfully, it will be either as a contraceptive or as 
an abortifacient. As we have seen, there does not seem to be any meaningful 
contraceptive effect which Ovral could have by the time the woman presents 
herself for post-rape treatment. As a result, if Ovral does anything meaningful 
from a physiological standpoint, it would be as an abortifacient rather than as a 
contraceptive in the post-rape context. Second, in the Principle of Double Effect 
the good effect cannot be obtained in some equally expeditious and effective way 
without the concomitant evil effect. This aspect of the Principle is clearly violated 
in the case of the post-rape administration of Ovral since there is virtually no 
chance of conception occurring in the first place. Thus, not administering Ovral is 
just as effective as administering Ovral, since its de facto effect is that of a placebo. 
Not administering Ovral is thus "equally expeditious and effective." Third, in the 
Principle of Double Effect there must be due proportion between the good that is 
intended and the evil that is permitted. In the calculation for this case, one could 
hardly state that there is a due proportion exhibited between the possible 
psychological solace of Ovral administered as a placebo and the possible 
destruction of an innocent human life in an undetected pregnancy. 
It is also common teaching that in a case where a fundamental human value 
such as human life may be at stake, the safer course is always to be preferred. As 
we have seen, in all likelihood the woman is not going to become pregnant in the 
first place. Thus, what reasons could be given for taking any risk of an 
abortifacient side effect by the administration of the Ovral treatment? 
In conclusion, Directive 12 ofthe Ethical and Religious Directives states that, 
"Every procedure whose sole immediate effect is the termination of pregnancy 
before viability is an abortion which, in its moral context, includes the interval 
between conception and implantation of the embryo." As indicated, it seems that 
there is no meaningful contraceptive effect postcoital for Ovral or similar 
treatments. By the time the woman presents herself for treatment, the "sole 
immediate effect" of Ovral is to render the endometrium hostile to a possible 
fertilized egg. This is the primary intention with which emergency room 
physicians prescribe it and the primary intention with which women take it. It is a 
simple fact that women and emergency room physicians are not usually 
interested in purely contraceptive devices at this time, even if Ovral were in that 
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category. It seems disingenuous for Catholic moralists to promote the Ovral 
treatment for its reputed contraceptive effects when in fact doctors neither 
prescribe nor do women take it for such purposes in the post-rape scenario. 
In making our ethical analysis of the use of Ovral or similar treatments in 
regards to post-rape scenario, we must take into consideration the possibility of 
scandal given or scandal taken, or more likely, scandal given and taken. I have yet 
to contact the non-Catholic physician who would not say that we are using a type 
of mental gymnastics to maintain that Ovral is truly a contraceptive in a post-rape 
protocol. If indeed Ovral has realistic contraceptive effects in such a scenario, it is 
a well kept secret among Catholic physicians. Non-Catholic physicians seem to 
find our "gnosis" quite bizarre. We do need to consider how those outside the 
Church will look upon the distinctions that some are trying to make in regards to 
Ovral. It does appear to many of them that this is nothing more than "loophole 
theology" in which we appear to be trying to find a way to circumvent our own 
ethical directives. 
Summary 
1) Catholic hospitals are required by law in many states to develop protocols 
for the aftercare of rape. 
2) Inclusion of "morning-after" pills in protocols has been justified by some 
authorities for use in the instance of sexual assault in the pre-ovulatory phase of a 
woman's cycle. 
3) Whereas the abortifacient effect of postcoital estrogen or estrogen-
progestogen administration is well established, the anti-ovulatory effect is highly 
questionable. 
4) The historical evidence provided by women as to their menstrual history is 
not reliable when evaluated by objective hormone-assay controlled methods. 
5) Given the logistics of the aftercare of rape victims in hospital emergency 
room settings, it would not be possible to eliminate the significant probability that 
postcoital hormone agents would be abortifacient in action. 
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Appendix I 
Proposed Supplementary Procedures to ACOG Protocol 
for the Examination and Treatment of Victims of Sexual Assault 
Time & Date of Examination: Time & Date of Alleged Assault: ______ _ 
Time elapsed since alleged assault: Date of LMP ________ _ 
Using contraception: Yes No If yes, what ____________________ _ 
Speculum examination. (Obtain all samples required in rape protocol). Then perform postcoital test. 
Is/ was conception possible or preventable? 
spermatozoa present - viable or dead 
Yes 
Cervical mucus has fertile characteristics: 
(estrogen effect) slippery, elastic, clear or cloudy. 
Obtain blood samples for LH, estrogen and 
progesterone levels (tests results will not be available 
in less than least 8 hours) 
no sperm seen 
highly unlikely 
no mucus, or sticky mucus 
(progesterone effect) 
no further pregnancy prevention treatment indicated, 
only usual anti-STD Rx and counseling Rx indicated. 
Perform vaginal ultrasound examination 
to evaluate presence & size of dominant follicle. 
If dominant follicle is seen (> 1.5 cm + in diameter, 
consider transvaginal aspiration of the ovum from the 
follicle under ultrasonic guidance. This requires 
special skills and instruments - an IVF or GIFT 
needle. 
If this is attempted by someone who is not a specialist 
in egg retrieval and in vitro fertilization there is a 
higher probability that the ovum will be spilled into 
the peritoneal cavity and become accessible to 
spermatozoa and conception [Since in vitro fertiliza-
tion and related procedures are proscribed by Donum 
Vitae it is not too likely that such specialists would be 
found in Catholic hospitals.] As the ACOG Rape 
Protocol estimates the risks of conception from rape 
to be 2-4% of women who are not already on 
contraception, counseling is indicated before attempt-
ing an egg removal! retrieval procedure. [The 
additional expense of the vaginal ultrasound exami-
nation can be viewed in several ways: traditionally, 
every procedure is expected to amortize the cost of the 
equipment, but since vaginal ultrasound is used 
regularly to diagnose, for instance, ectopic pregnancy, 
it is already available.] 
If no dominant follicle is seen, ovulation has passed, 
or is not imminent. 
Rx: counseling and anti-STD protocol. 
If there is no trained physician available, an 
interventional radiologist can perform the procedure 
transabdominally. This would not be done on an 
emergency basis. Blood hormone levels would be 
a vailable and helpful; on the other hand if ovulation 
was imminent, it may have occurred in the interim. 
Above algorithm provided by Hanna Klaus, M.D. 
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Appendix D 
Dr. Thomas Hilgers has proposed the following procedure as a research 
project to evaluate a definitive program to prevent pregnancy after rape. 
A. Upon examining the rape victim, the physician studies the cervical 
mucus for the presence or absence offerning. If the fern ofthe cervical 
mucus is negative, then there is no need for any further evaluation or 
treatment. If the ferning is positive, then it suggests that the cervix is 
being stimulated by estrogen and ovulation is either approaching or is 
just past. If the feming is positive, then the physician goes to step B. 
B. The patient with a positive fern then undergoes a pelvic ultrasound 
examination looking for the presence of a follicle or a recently formed 
corpus luteum. Also, the evaluation of the endometrium can be 
undertaken to define whether or not the endometrium is proliferative or 
secretory. In the presence of a follicle, the physician goes to step C. 
C. With step C, the patient is given a continuous infusion of Gonadotropin 
Releasing Hormone (GnRH). With a continuous infusion of GnRH the 
further development of the follicle should be stopped "in its tracks" and 
ovulation will not occur. 
D. In the case where the ultrasound reveals the corpus luteum, no further 
treatment would be necessary. It is possible, although very unlikely, that 
a recently formed corpus luteum would reflect the possibility of 
pregnancy. At the same time, the possibility does exist that it would 
reflect an early postovulatory situation where pregnancy might occur 
but only further evaluation would allow for that consideration to be 
better defined. 
E. If the patient does become pregnant, then a pregnancy support program 
should be available since studies and experience do suggest that these 
patients do as well carrying the pregnancy as they do having had the 
abortion. 
The above research protocol deserves funding from sources such as the Catholic 
Health Association or the NCCB as a means of resolving some of the of 
controversies. 
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